RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVCR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for NovoCure Limited stock price on Wednesday moving between $12.92 and $15.49
(Updated on Mar 27, 2024)

Hold candidate since Mar 27, 2024 PDF

The NovoCure Limited stock price gained 12.01% on the last trading day (Wednesday, 27th Mar 2024), rising from $13.07 to $14.64. During the last trading day the stock fluctuated 19.89% from a day low at $12.92 to a day high of $15.49. The price has fallen in 7 of the last 10 days and is down by -1.21% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 11 million more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $174.47 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.72% during the next 3 months and, with a 90% probability hold a price between $13.83 and $18.51 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVCR Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 12.01%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The NovoCure Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $15.18. On a fall, the stock will find some support from the short-term average at $13.61. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NovoCure Limited stock

NovoCure Limited finds support from accumulated volume at $14.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.57 between high and low, or 19.89%. For the last week, the stock has had daily average volatility of 7.93%.

Our recommended stop-loss: $14.00 (-4.40%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (NVCR) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect NovoCure Limited to open at $14.35, and during the day (based on 14 day Average True Range), to move between $13.71 and $15.57, which gives a possible trading interval of +/-$0.93 (+/-6.37%) up or down from last closing price. If NovoCure Limited takes out the full calculated possible swing range there will be an estimated 12.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.50 (0.96%) than the resistance at $15.31 (4.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NovoCure Limited stock A Buy?

NovoCure Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.915 Hold/Accumulate Upgraded

Predicted Opening Price for NovoCure Limited of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$14.35 ( 1.98%) $14.64

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVCR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.92 15.57 %
R2 15.94 8.87 %
R1 15.33 4.73 %
Current price: 14.64
Support S1 13.37 -8.69 %
S2 12.76 -12.83 %
S3 11.78 -19.54 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.78 7.79 %
R2 15.62 6.69 %
R1 15.31 4.58 %
Current price 14.64
Support S1 14.50 -0.96%
S2 13.98 -4.51%
S3 13.54 -7.51%

FAQ

What is the symbol for NovoCure Limited Stock and on which exchange is it traded?
The symbol for NovoCure Limited is NVCR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NovoCure Limited Stock?
NovoCure Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy NovoCure Limited Stock?
NovoCure Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NovoCure Limited Stock.

What's the current price of NovoCure Limited Stock?
As of the end of day on the 2024-03-27, the price of an NovoCure Limited (NVCR) share was $14.64.

What is the 52-week high and low for NovoCure Limited Stock?
The 52-week high for NovoCure Limited Stock is $83.60 and the 52-week low is $10.87.

What is the market capitalization of NovoCure Limited Stock?
As of the 2024-03-27, the market capitalization of NovoCure Limited is 1.4B.

When is the next earnings date for NovoCure Limited?
The upcoming earnings date for NovoCure Limited is May 02, 2024.
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT